UNSPSC 41106514: Stable mammalian cell lines

UNSPSC 41106514 Stable mammalian cell lines is a Commodity code, but the recent state and local procurement activity tagged under this code shows no meaningful alignment with the abstract code name. The opportunities posted in the dataset under 41106514 include laboratory equipment (spectrometers, cameras, induction furnaces, microscopes), research instrumentation (ion beam systems, cold spray additive manufacturing platforms, rheological analyzers), consumable supplies (fire alarm components, water testing reagents, drone systems), and athletic equipment—none of which are stable mammalian cell lines or cell-culture products. One record explicitly notes a file mismatch, and several lack substantive scope detail. The code appears to be either systematically miscoded by issuing procurement offices or assigned to records in error; state and local government activity under the code does not reflect the taxonomy definition.

Mississippi State University dominates the recent activity under 41106514, posting more than twenty sole-source notices between June and October 2026, followed by the University of Wisconsin-Madison, the University of Mississippi, Texas A&M University System, and the University of Southern Mississippi. County and municipal agencies (Harris County, Texas; Escambia County, Florida; City of Philadelphia; Illinois State Police; State of Oregon; State of Mississippi; Texas Health and Human Services Commission) appear sporadically. Most opportunities are sole-source procurements or restricted brand-name purchases (RFINs, RFQs, and IFBs) with objection or response windows closing within one to three weeks of posting. Representative recent solicitations include Mississippi State University's sole-source notice for a CEAD B.V. AM Flexbot hybrid 3D printing system (September 11, 2026, RFP response due September 25, 2026, estimated $1.253 million) and University of Wisconsin-Madison's RFB for an RF-shielded anechoic chamber and antenna positioner system (July 31, 2026, RFB due August 14, 2026). Geographic concentration is highest in Mississippi and Wisconsin, with scattered activity across Texas, Illinois, Oregon, and Florida. Because the code shows no verifiable state or local procurement for mammalian cell lines or cell-culture products, the category warrants skip status unless the source data errors are resolved upstream.